Senior Director, GSK || Medicine & Vaccine Design || ABRYSVO®, COMIRNATY®, LUTFULO®
Cambridge, MA
Joined October 2013
- Tweets201
- Following2K
- Followers984
- Likes55.3K
Ye Che retweeted
Today, we announced the @US_FDA has approved our bivalent RSV prefusion F (RSVpreF) vaccine, for the prevention of #RSV in infants from birth up to six months of age by active immunization of pregnant individuals at 32-36 weeks gestational age. Read more: on.pfizer.com/3KR2vC9
Ye Che retweeted
BREAKING: Today, we announced that the @EMA_News #CHMP has adopted a positive opinion for our bivalent RSV prefusion F (RSVpreF) vaccine candidate for both older adults and maternal immunization to help protect infants. Read more: on.pfizer.com/43D064i
A huge milestone for Pfizer covalent JAK3/TEC inhibitor was achieved by the phenomenal Pfizer team! Our Covalent Drug Platform that ultimately delivered LITFULO and a robust platform to assess and derisk electrophile reactivity and safety of covalent drug…lnkd.in/efzRVVya
Ye Che retweeted
It’s been an encouraging couple of days in the world of respiratory health. @CDCgov’s #ACIP has voted to recommend our RSV vaccine for adults ≥60yo (on.pfizer.com/3phSUN3), and our pneumococcal conjugate vaccine for infants and children (on.pfizer.com/3pnydzh).
These decisions are an important step as we continue working to help people protect themselves and their loved ones from respiratory diseases.
#Vaccine is safe and important. #RSV should be added to the list. #pfecolleague #pfizerproud lnkd.in/etkbrjZH
Looking forward to meeting many friends in the coming NERM2023 conference! Many thanks @YuanHu_Pharma and Srinivasa Karra for organizing the event. #pfecolleague #pfizerproud lnkd.in/eiD5d5du
Ye Che retweeted
Thrilled that #VRBPAC has voted independently to recommend our maternal RSV vaccine candidate to @US_FDA. In the United States, ~500,000 to 600,000 cases of medically attended lower respiratory tract disease due to RSV occur annually in infants <12mo. This is an important step toward what could be the first-ever maternal immunization vaccine to help protect infants from birth through 6 months from this contagious respiratory illness. on.pfizer.com/3WiVgXV
Ye Che retweeted
BREAKING: Today, the @US_FDA Vaccines and Related Biological Committee (#VRBPAC) voted in support of approval for our vaccine candidate to help prevent RSV in infants through maternal immunization.
Read more: pfizer.com/news/press-releas…
A nice historical prospective (lnkd.in/ej4VTXpD) from the TIME magazine on 𝗪𝗵𝘆 𝗜𝘁 𝗧𝗼𝗼𝗸 𝗦𝗼 𝗟𝗼𝗻𝗴 𝘁𝗼 𝗙𝗶𝗻𝗮𝗹𝗹𝘆 𝗚𝗲𝘁 𝗮𝗻 𝗥𝗦𝗩 𝗩𝗮𝗰𝗰𝗶𝗻𝗲: Paul Glezen of the Baylor College of Medicine made one of the first important disc…lnkd.in/e3mqAEJA
Industry-best structural biology team! An impactful example of structure-based design leading to clinic success. #pfizerproud #pfecolleague lnkd.in/ea7M8HVN
PROUD to share a Pfizer PUBLICATION (lnkd.in/eJKR7bTV) on Science Translational Medicine jointly from DISCOVERY SCIENCES and VACCINES R&D: Great collaborative efforts on combining our strengths in protein design and engineering, high throughput mut…lnkd.in/eAJbi--A
Ye Che retweeted
As RSV cases continue to rise, I’m thrilled to share that @US_FDA has accepted for priority review our RSV vaccine candidate for adults 60yo and over, shortening the review period by 4 mos for what we hope is a new option to help tackle this disease: on.pfizer.com/3P90HW7
Ye Che retweeted
Last week, Prevnar 13 received the Silver Medal for Best Vaccine at the 2022 Prix Galien Golden Jubilee Awards. What an amazing recognition for our global team, who have spent decades developing and distributing this vaccine. Congratulations! I am so #PfizerProud of you!
Ye Che retweeted
Very proud of both our Q3 financial results & the strong foundation we have built for growth. From RSV, to UC, to migraines—and more, we expect to launch up to 19 new products or indications in the next 18mos to help address a range of patient needs: on.pfizer.com/Q3 $PFE
People of all ages are affected by respiratory syncytial virus or #RSV, but the risk increases in older adults. I’m #PfizerProud of my contributions to develop the RSVpreF vaccine. #RSVAwarenessMonth #PFEColleague bit.ly/3mw90x6
We’re hiring in CT! Watch below to see our colleagues share their experiences working at Pfizer Groton and head to Pfizer.com/careers for open jobs. #PFEColleague bit.ly/3lk5kPR
Proud of our heritage in bringing breakthroughs that change patients' lives. #PFEColleague bit.ly/3kdBxI5
#PfizerProud of our commitment to researching an investigational vaccine candidate that could potentially prevent #RSV. Congrats to the RSV team again!! #PFEColleague bit.ly/3DOhaJg
Ye Che retweeted
We know vaccines can have significant impact on people’s lives & we're leveraging our scientific expertise toward research & development of a potential first vaccine to prevent RSV disease. Today, we announced the start of a Phase 3 trial in older adults: pfizer.com/news/press-releas…
So proud to work for @Pfizer with the amazing news we feature as a @Forbes Best Employer for Women in 2021. 👏🎉 #BestEmployersforWomen #PfizerProud #PFEColleague bit.ly/3yb8Mzt